» Articles » PMID: 33139626

Nutrition in Cancer Therapy in the Elderly-An Epigenetic Connection?

Overview
Journal Nutrients
Date 2020 Nov 3
PMID 33139626
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The continuous increase in life expectancy results in a steady increase of cancer risk, which consequently increases the population of older adults with cancer. Older adults have their age-related nutritional needs and often suffer from comorbidities that may affect cancer therapy. They frequently are malnourished and present advanced-stage cancer. Therefore, this group of patients requires a special multidisciplinary approach to optimize their therapy and increase quality of life impaired by aging, cancer, and the side effects of therapy. Evaluation strategies, taking advantage of comprehensive geriatric assessment tools, including the comprehensive geriatric assessment (CGA), can help individualize treatment. As epigenetics, an emerging element of the regulation of gene expression, is involved in both aging and cancer and the epigenetic profile can be modulated by the diet, it seems to be a candidate to assist with planning a nutritional intervention in elderly populations with cancer. In this review, we present problems associated with the diet and nutrition in the elderly undergoing active cancer therapy and provide some information on epigenetic aspects of aging and cancer transformation. Nutritional interventions modulating the epigenetic profile, including caloric restriction and basal diet with modifications (elimination diet, supplementary diet) are discussed as the ways to improve the efficacy of cancer therapy and maintain the quality of life of older adults with cancer.

Citing Articles

Narrative review: nutritional strategies for ageing populations - focusing on dysphagia and geriatric nutritional needs.

Cava E, Lombardo M Eur J Clin Nutr. 2024; .

PMID: 39414983 DOI: 10.1038/s41430-024-01513-w.


Association of hemoglobin, albumin, lymphocyte, and platelet score with risk of all-cause and cause-specific mortality among cancer survivors: NHANES 1999-2018.

Fu J, Yue X, Zou Y, Zhang J, Wang X, Zhang D Front Oncol. 2024; 14:1402217.

PMID: 39359427 PMC: 11445657. DOI: 10.3389/fonc.2024.1402217.


Geriatric Nutritional Risk Index as Prognostic Marker for Elderly Patients With Small Cell Lung Cancer.

Kinoshita R, Nakao M, Kiyotoshi H, Sugihara M, Kuriyama M, Takeda N Cancer Diagn Progn. 2024; 4(4):482-488.

PMID: 38962547 PMC: 11215438. DOI: 10.21873/cdp.10352.


Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy.

Jang J, Oh D, Noh J, Sun J, Kim H, Shim Y J Cachexia Sarcopenia Muscle. 2024; 15(3):1167-1176.

PMID: 38613258 PMC: 11154764. DOI: 10.1002/jcsm.13462.


Exploring the potential of VGLL3 methylation as a prognostic indicator for intracranial aneurysm with gender-specific considerations.

Liu Y, Chen S, Zhang E, Xu Y, Deng X, Hu Z Biosci Rep. 2024; 44(3).

PMID: 38348744 PMC: 10912501. DOI: 10.1042/BSR20231374.


References
1.
Arends J, Baracos V, Bertz H, Bozzetti F, Calder P, Deutz N . ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017; 36(5):1187-1196. DOI: 10.1016/j.clnu.2017.06.017. View

2.
Longo V, Antebi A, Bartke A, Barzilai N, Brown-Borg H, Caruso C . Interventions to Slow Aging in Humans: Are We Ready?. Aging Cell. 2015; 14(4):497-510. PMC: 4531065. DOI: 10.1111/acel.12338. View

3.
Norman H, Butrum R, Feldman E, Heber D, Nixon D, Picciano M . The role of dietary supplements during cancer therapy. J Nutr. 2003; 133(11 Suppl 1):3794S-3799S. DOI: 10.1093/jn/133.11.3794S. View

4.
Issa J . Epigenetic variation and human disease. J Nutr. 2002; 132(8 Suppl):2388S-2392S. DOI: 10.1093/jn/132.8.2388S. View

5.
Colman R, Anderson R, Johnson S, Kastman E, Kosmatka K, Beasley T . Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325(5937):201-4. PMC: 2812811. DOI: 10.1126/science.1173635. View